Analyses of gene expression from the ALL project of the TARGET Program demonstrated strong positive correlations of SIG15 expression with markers of PKC, calcineurin, and NFκB activity in pediatric B-ALL samples (Fig. 2E). This evidence concerns the gene PRRT2 and precursor B-cell acute lymphoblastic leukemia.